NEW YORK (Reuters) - The proposed merger between U.S. pharmacy operator CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion (£50.28 billion) bet that insurers can drive down high U.S. drug prices by cutting out the middleman.
UK: CVS bid for Aetna - A $66 billion bet on cutting drug costs
Reviewed by Shahid Karimi
on
October 29, 2017
Rating: 5
No comments: